Endocrine activities of alexamorelin (Ala-His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2), a synthetic GH secretagogue, in humans

European Journal of Endocrinology

Volumn 143, Issue 3, 2000, Pages 419-425

  Broglio, F ^a   Benso, A ^a   Gottero, C ^a   Muccioli, G ^a   Deghenghi, R ^a   Ghigo, E ^a   Arvat, E ^a  

^a MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALEX; ALEXAMORELIN; GROWTH HORMONE DERIVATIVE; HEX; UNCLASSIFIED DRUG;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG STRUCTURE; ENDOCRINE FUNCTION; FLUSHING; GROWTH HORMONE BLOOD LEVEL; HORMONE ACTION; HORMONE RESPONSE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL;

EID: 0033794886     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1430419     Document Type: Article

References (34)

1. Atypical growth hormone releasing peptides
2. Growth hormone-releasing peptides
3. Peptidomimetic regulation of growth hormone secretion
4. Growth hormone-releasing peptide and its analogues. Novel stimuli to growth hormone release
5. Growth hormone secretagogue as corticotrophin-releasing factors
6. A receptor in pituitary and hypothalamus that functions in growth hormone release
7. Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland
8. 125I-p-benzoyl-phenylalanine hexarelin derivative
9. Cloning and characterization of two human G-protein-coupled receptor genes (GPR38 and GPR39) related to the growth hormone secretagogues and neurotensin receptors
10. Cloning and characterization of a human and murine T-cell orphan G-protein-coupled receptor similar to the growth hormone secretagogue and neurotensin receptors
11. Receptor for motilin identified in the human gastrointestinal system
12. Ghrelin is a growth-hormone-releasing acylated peptide from stomach
13. Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: Evidence that GHRP-6 main action is exerted at the hypothalamic level
14. Mediation by the central nervous system is critical to the in vivo activity of the GH secretagogue L-692,585
15. Small peptides as potent releasers of growth hormone
16. Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH
17. Tyr-alexarelin, a synthetic octapeptide, possesses the same endocrine activities of hexarelin and GHRP-6 in humans
18. Pharmacological characterization of a new oral GH secretagogue, NN703
19. Ipamorelin, the first selective growth hormone secretagogue
20. Effects of 7-day treatment with a novel orally active, growth hormone (GH) secretagogue, MK-677, on 24-h GH profiles, insulin-like growth factor I, and adrenocortical function in normal young men
21. Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretagogue (MK-677) in healthy elderly subjects
22. Small impervious peptides as GH secretagogues
23. Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats
24. A new series of highly potent growth hormone-releasing peptides derived from ipamorelin
25. Tissue distribution of GHRP receptors in humans
26. Plasma adrenocorticotropin, cortisol and aldosterone responses to corticotropin-releasing factor: Modulatory effect of basal cortisol levels
27. Dose-response relationships between plasma adrenocorticotropin (ACTH), cortisol, aldosterone and 18-hydroxycorticosterone after injection of ACTH-(1-39) or human corticotropin-releasing hormone in man
28. Stimulatory effect of ACTH on cortisol, aldosterone and dehydroepiandrosterone secretion in normal humans
29. Responses of plasma adrenocortical steroids to low dose ACTH in normal subjects
30. Growth hormone-releasing peptides and the cardiovascular system
31. The growth hormone secretagogue hexarelin improves cardiac function in rats after experimental myocardial infarction
32. Growth hormone-independent cardioprotective effects of hexarelin in the rat
33. Rapid cardiovascular action of aldosterone in man
34. Hexarelin exhibits protective activity against cardiac ischaemia in hearts from growth hormone-deficient rats